Bruker (BRKR) Common Equity (2010 - 2026)
Bruker's (BRKR) quarterly Common Equity came in at $2.5 billion in Q1 2026, up 34.6% YoY from $1.8 billion in Q1 2025, and little changed on a QoQ basis from $2.5 billion in Q4 2025.
Bruker (BRKR) Common Equity (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 17 years of Common Equity data on file, last reported at $2.5 billion in Q1 2026.
- Quarterly Common Equity rose 34.6% year-over-year to $2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 billion (up 34.6% YoY) and the FY2025 annual result came in at $2.5 billion, up 37.64% from the prior year.
- Common Equity was little changed at $2.5 billion in Q1 2026, from $2.5 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $2.5 billion in Q4 2025 to a low of $948.0 million in Q3 2022.
- A 5-year average of $1.6 billion and a median of $1.4 billion in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity retreated 13.0% — and 2024, when it surged 48.73%.
- Tracing BRKR's Common Equity over 5 years: stood at $1.1 billion in 2022, then gained by 23.89% to $1.4 billion in 2023, then increased by 28.86% to $1.8 billion in 2024, then jumped by 37.64% to $2.5 billion in 2025, then retreated by 0.26% to $2.5 billion in 2026.
- The last three Common Equity figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Bruker | 9.23 Bn | 9.23 Bn | 416.00 Mn | 2.40 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.40 Bn |
| Mar 31, 2026 | 2.47 Bn |
| Dec 31, 2025 | 2.47 Bn |
| Sep 30, 2025 | 2.43 Bn |
| Jun 30, 2025 | 1.82 Bn |
| Mar 31, 2025 | 1.83 Bn |
| Dec 31, 2024 | 1.80 Bn |
| Sep 30, 2024 | 1.83 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 1.43 Bn |
| Dec 31, 2023 | 1.39 Bn |
| Sep 30, 2023 | 1.23 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 948.00 Mn |
| Jun 30, 2022 | 984.40 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 1.08 Bn |
| Sep 30, 2021 | 1.09 Bn |